PDF factsheet
      Z

ticagrelor for acute coronary syndrome clinical trials results

ticagrelor versus clopidogrel
PLATO, 2009
NCT00391872
ticagrelor 90mg twice daily
versus
clopidogrel 75mg once daily
patients with an acute coronary syndrome, with or without ST-segment elevation (onset of symptoms within the previous 24h). double blind
Follow-up duration: 1 y
43 countries
DISPERSE-2 (90mg), 2007
ticagrelor 90 mg twice daily
versus
clopidogrel
patients with NSTE-ACS, treated with aspirin and standard therapy for ACSdouble blind
Follow-up duration: 12 weeks

  Options


in first

in second

  Filter